Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Reuss

Showing results (121-130 of 136) with videos related to

Pageof 14
Sort By:
Acta Neuropathologica Communications|October 30, 2019
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entitiesAnnekathrin Reinhardt, Damian Stichel, Daniel Schrimpf, et al.
Neuro-Oncology|July 22, 2025
Distinct molecular profile and outcome of oligodendroglioma, IDH-mutant, 1p/19q-codeleted and TERTp-wildtype: a grade 1 oligodendroglioma of young patients?Filippo Nozzoli, Ramin Rahmanzade, Simone Schmid, et al.
Nature Medicine|December 12, 2018
The molecular landscape of glioma in patients with Neurofibromatosis 1Fulvio D'Angelo, Michele Ceccarelli, Tala, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Novel Predictive Spatial Biomarker in Non-Small Cell Lung Carcinoma: The Diversity of Niches Unlocking Treatment Sensitivity (DONUTS)Tricia R Cottrell, Jeffrey S Roskes, Michael Fotheringham, et al.
Neuro-Oncology|June 3, 2026
Primary Mismatch Repair Deficient Glioma (PMMRDG), IDH-wildtype and H3-wildtype: A Giant Cell Tumor with Potential for Long-Term Survival Occurring at all AgesAbigail K Suwala, Dennis Friedel, Felix E Hinz, et al.
Acta Neuropathologica|April 25, 2018
Novel, improved grading system(s) for IDH-mutant astrocytic gliomasMitsuaki Shirahata, Takahiro Ono, Damian Stichel, et al.
The Lancet. Oncology|March 19, 2017
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysisFelix Sahm, Daniel Schrimpf, Damian Stichel, et al.
Acta Neuropathologica|March 18, 2023
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusionsHenri Bogumil, Martin Sill, Daniel Schrimpf, et al.
Acta Neuropathologica|February 3, 2025
IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spreadFelix Hinz, Dennis Friedel, Andrey Korshunov, et al.
Acta Neuropathologica|September 30, 2019
Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease courseAnnika K Wefers, Damian Stichel, Daniel Schrimpf, et al.
Pageof 14

Showing results (121-130 of 136) with videos related to

Sort By:
Pageof 14
Acta Neuropathologica Communications|October 30, 2019
Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entitiesAnnekathrin Reinhardt, Damian Stichel, Daniel Schrimpf, et al.
Neuro-Oncology|July 22, 2025
Distinct molecular profile and outcome of oligodendroglioma, IDH-mutant, 1p/19q-codeleted and TERTp-wildtype: a grade 1 oligodendroglioma of young patients?Filippo Nozzoli, Ramin Rahmanzade, Simone Schmid, et al.
Nature Medicine|December 12, 2018
The molecular landscape of glioma in patients with Neurofibromatosis 1Fulvio D'Angelo, Michele Ceccarelli, Tala, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Novel Predictive Spatial Biomarker in Non-Small Cell Lung Carcinoma: The Diversity of Niches Unlocking Treatment Sensitivity (DONUTS)Tricia R Cottrell, Jeffrey S Roskes, Michael Fotheringham, et al.
Neuro-Oncology|June 3, 2026
Primary Mismatch Repair Deficient Glioma (PMMRDG), IDH-wildtype and H3-wildtype: A Giant Cell Tumor with Potential for Long-Term Survival Occurring at all AgesAbigail K Suwala, Dennis Friedel, Felix E Hinz, et al.
Acta Neuropathologica|April 25, 2018
Novel, improved grading system(s) for IDH-mutant astrocytic gliomasMitsuaki Shirahata, Takahiro Ono, Damian Stichel, et al.
The Lancet. Oncology|March 19, 2017
DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysisFelix Sahm, Daniel Schrimpf, Damian Stichel, et al.
Acta Neuropathologica|March 18, 2023
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusionsHenri Bogumil, Martin Sill, Daniel Schrimpf, et al.
Acta Neuropathologica|February 3, 2025
IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spreadFelix Hinz, Dennis Friedel, Andrey Korshunov, et al.
Acta Neuropathologica|September 30, 2019
Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease courseAnnika K Wefers, Damian Stichel, Daniel Schrimpf, et al.
Pageof 14